Global Campaign for Microbicides

Home

Home » About Microbicides » Testing & Trials » Trial Results » Resources about the CAPRISA 004 Trial and Results

Resources about the CAPRISA 004 Trial and Results

GCM's CAPRISA 004 Q&A

 

GCM’s Background Paper on CAPRISA 004

 

CAPRISA 004 Adherence factsheet 20 July 2010

 

CAPRISA 004 Drug resistance factsheet 20 July 2010

 

CAPRISA 004 HSV-2 factsheet 20 July 2010

 

CAPRISA 004 Safety factsheet 20 July 2010

 

CAPRISA 004 Backgrounder 20 July 2010

 

CAPRISA 004 Effectiveness factsheet 20 July 2010

 

CAPRISA 004 Pregnancy factsheet 20 July 2010

 

CAPRISA 004 Q and A 20 July 2010

 

CAPRISA 004 Summary factsheet 20 July 2010

 

MTN's CAPRISA 004 Fact Sheet

 

Link to the Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women, data published in Science.

 

Link to Safety and Effectiveness of 1% Tenofovir Vaginal Microbicide Gel in South African Women: Results of the CAPRISA 004 Trial (Kaiser Family Foundation)